Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
BING NEWS:
  • Instant pleasure: Vivus ED pill wins faster-acting 'on demand' label
    The FDA on Thursday approved a revised label for Vivus' erectile dysfunction pill Stendra. Auxilium, which won marketing rights to Stendra in a deal that could be worth as much as $300 million, can now market the drug for use 15 minutes before sex rather ...
    09/17/2014 - 1:00 pm | View Link
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:32 pm | View Link
  • Vivus' Erectile Dysfunction Drug Stendra Wins FDA Approval
    Law360, New York (April 27, 2012, 8:00 PM EDT) -- The U.S. Food and Drug Administration on Friday approved Vivus Inc.'s erectile dysfunction pill Stendra, the first erectile dysfunction treatment to be allowed for use in the U.S. in a decade and the first ...
    04/27/2012 - 1:00 pm | View Link
  • Vivus weight-loss drug faces key U.S. test
    If Qnexa wins a green light from FDA, that figure could soar. Analysts estimate Vivus' drug could take in nearly $689 million in sales by 2014, according to consensus forecast data from Thomson Reuters. Current weight-loss drugs have not gained much ...
    07/15/2010 - 3:00 am | View Link
  • CORRECTED-Vivus' weight-loss drug faces key U.S. test
    If Qnexa wins the FDA's green light, that could more than double. Analysts estimate Vivus' drug could take in nearly $689 million in sales by 2014, according to consensus forecast data from Thomson Reuters. It would be the second U.S. drug for the biotech ...
    07/15/2010 - 1:11 am | View Link
  • More
BING SEARCH:
  • Medical Devices | FierceBiotech
    The FDA has issued a warning about two devices used to treat obesity after receiving upward of 40 reports of adverse events.
    02/16/2017 - 10:33 am | View Website
  • Marketing | FiercePharma
    Regeneron and Sanofi won’t have to pull Praluent off the market, at least not yet. A U.S. appeals court has stayed an injunction against the drug, pending an…
    02/16/2017 - 10:26 am | View Website
  • ChinaBio® Today
    ChinaBio Leadership Retreat 2013 - Registration; Top Stories; Hutchison MediPharma Out-licenses Cancer Drug to Lilly for $86.5 Million; Eddingpharm Pays $2.7 Million ...
    02/16/2017 - 8:17 am | View Website
  • Today's Stock Market News and Analysis
    Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more.
    02/16/2017 - 4:06 am | View Website
  • Teva Pharmaceutical Industries, Ltd.
    At Teva Pharmaceutical Industries, we improve people's health through our products, integrated R&D, generic medicines and global businesses
    02/15/2017 - 10:44 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News